Innova Captab Limited (NSE:INNOVACAP)

Market Cap	50.50B
Revenue (ttm)	12.56B
Net Income (ttm)	1.28B
Shares Out	57.22M
EPS (ttm)	22.41
PE Ratio	39.38
Forward PE	30.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,832
Average Volume	61,066
Open	882.95
Previous Close	882.55
Day's Range	860.10 - 890.70
52-Week Range	421.35 - 1,260.00
Beta	n/a
RSI	47.34
Earnings Date	May 29, 2025

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antieme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In 2024, Innova Captab's revenue was 12.56 billion, an increase of 16.13% compared to the previous year's 10.81 billion. Earnings were 1.28 billion, an increase of 35.95%.